BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 16847317)

  • 1. Targeted disruption of the mouse phosphomannomutase 2 gene causes early embryonic lethality.
    Thiel C; Lübke T; Matthijs G; von Figura K; Körner C
    Mol Cell Biol; 2006 Aug; 26(15):5615-20. PubMed ID: 16847317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The normal phenotype of Pmm1-deficient mice suggests that Pmm1 is not essential for normal mouse development.
    Cromphout K; Vleugels W; Heykants L; Schollen E; Keldermans L; Sciot R; D'Hooge R; De Deyn PP; von Figura K; Hartmann D; Körner C; Matthijs G
    Mol Cell Biol; 2006 Aug; 26(15):5621-35. PubMed ID: 16847318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Congenital disorder of glycosylation type Ia: searching for the origin of common mutations in PMM2.
    Quelhas D; Quental R; Vilarinho L; Amorim A; Azevedo L
    Ann Hum Genet; 2007 May; 71(Pt 3):348-53. PubMed ID: 17166182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue distribution of the murine phosphomannomutases Pmm1 and Pmm2 during brain development.
    Cromphout K; Keldermans L; Snellinx A; Collet JF; Grünewald S; De Geest N; Sciot R; Vanschaftingen E; Jaeken J; Matthijs G; Hartmann D
    Eur J Neurosci; 2005 Aug; 22(4):991-6. PubMed ID: 16115222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Effects of PMM2-CDG-Causing Mutations on the Folding, Activity, and Stability of the PMM2 Protein.
    Yuste-Checa P; Gámez A; Brasil S; Desviat LR; Ugarte M; Pérez-Cerdá C; Pérez B
    Hum Mutat; 2015 Sep; 36(9):851-60. PubMed ID: 26014514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful prenatal mannose treatment for congenital disorder of glycosylation-Ia in mice.
    Schneider A; Thiel C; Rindermann J; DeRossi C; Popovici D; Hoffmann GF; Gröne HJ; Körner C
    Nat Med; 2011 Dec; 18(1):71-3. PubMed ID: 22157680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A mouse model of a human congenital disorder of glycosylation caused by loss of PMM2.
    Chan B; Clasquin M; Smolen GA; Histen G; Powe J; Chen Y; Lin Z; Lu C; Liu Y; Cang Y; Yan Z; Xia Y; Thompson R; Singleton C; Dorsch M; Silverman L; Su SM; Freeze HH; Jin S
    Hum Mol Genet; 2016 Jun; 25(11):2182-2193. PubMed ID: 27053713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a IVS4-58delATG polymorphism in the human phosphomannomutase 2 (PMM2) gene.
    Vuillaumier-Barrot S; Bizec CL; Durand G; Grandchamp B; Seta N
    Hum Mutat; 2000 May; 15(5):486. PubMed ID: 10790224
    [No Abstract]   [Full Text] [Related]  

  • 9. Characterization of two unusual truncating PMM2 mutations in two CDG-Ia patients.
    Schollen E; Keldermans L; Foulquier F; Briones P; Chabas A; Sánchez-Valverde F; Adamowicz M; Pronicka E; Wevers R; Matthijs G
    Mol Genet Metab; 2007 Apr; 90(4):408-13. PubMed ID: 17307006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetic properties and tissular distribution of mammalian phosphomannomutase isozymes.
    Pirard M; Achouri Y; Collet JF; Schollen E; Matthijs G; Van Schaftingen E
    Biochem J; 1999 Apr; 339 ( Pt 1)(Pt 1):201-7. PubMed ID: 10085245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synaptic roles for phosphomannomutase type 2 in a new Drosophila congenital disorder of glycosylation disease model.
    Parkinson WM; Dookwah M; Dear ML; Gatto CL; Aoki K; Tiemeyer M; Broadie K
    Dis Model Mech; 2016 May; 9(5):513-27. PubMed ID: 26940433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycomic Characterization of Induced Pluripotent Stem Cells Derived from a Patient Suffering from Phosphomannomutase 2 Congenital Disorder of Glycosylation (PMM2-CDG).
    Thiesler CT; Cajic S; Hoffmann D; Thiel C; van Diepen L; Hennig R; Sgodda M; Weiβmann R; Reichl U; Steinemann D; Diekmann U; Huber NM; Oberbeck A; Cantz T; Kuss AW; Körner C; Schambach A; Rapp E; Buettner FF
    Mol Cell Proteomics; 2016 Apr; 15(4):1435-52. PubMed ID: 26785728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PMM2-CDG: phenotype and genotype in four affected family members.
    Bortot B; Cosentini D; Faletra F; Biffi S; De Martino E; Carrozzi M; Severini GM
    Gene; 2013 Dec; 531(2):506-9. PubMed ID: 23988505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional analysis of three splicing mutations identified in the PMM2 gene: toward a new therapy for congenital disorder of glycosylation type Ia.
    Vega AI; Pérez-Cerdá C; Desviat LR; Matthijs G; Ugarte M; Pérez B
    Hum Mutat; 2009 May; 30(5):795-803. PubMed ID: 19235233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphomannomutase activity in congenital disorders of glycosylation type Ia determined by direct analysis of the interconversion of mannose-1-phosphate to mannose-6-phosphate by high-pH anion-exchange chromatography with pulsed amperometric detection.
    Orvisky E; Stubblefield B; Long RT; Martin BM; Sidransky E; Krasnewich D
    Anal Biochem; 2003 Jun; 317(1):12-8. PubMed ID: 12729595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased biosynthesis of glycosphingolipids in congenital disorder of glycosylation Ia (CDG-Ia) fibroblasts.
    Sala G; Dupré T; Seta N; Codogno P; Ghidoni R
    Pediatr Res; 2002 Nov; 52(5):645-51. PubMed ID: 12409508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydrophobic Man-1-P derivatives correct abnormal glycosylation in Type I congenital disorder of glycosylation fibroblasts.
    Eklund EA; Merbouh N; Ichikawa M; Nishikawa A; Clima JM; Dorman JA; Norberg T; Freeze HH
    Glycobiology; 2005 Nov; 15(11):1084-93. PubMed ID: 16079417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A zebrafish model of PMM2-CDG reveals altered neurogenesis and a substrate-accumulation mechanism for N-linked glycosylation deficiency.
    Cline A; Gao N; Flanagan-Steet H; Sharma V; Rosa S; Sonon R; Azadi P; Sadler KC; Freeze HH; Lehrman MA; Steet R
    Mol Biol Cell; 2012 Nov; 23(21):4175-87. PubMed ID: 22956764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Yeast Models of Phosphomannomutase 2 Deficiency, a Congenital Disorder of Glycosylation.
    Lao JP; DiPrimio N; Prangley M; Sam FS; Mast JD; Perlstein EO
    G3 (Bethesda); 2019 Feb; 9(2):413-423. PubMed ID: 30530630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and localization of two mouse phosphomannomutase genes, Pmm1 and Pmm2.
    Heykants L; Schollen E; Grünewald S; Matthijs G
    Gene; 2001 May; 270(1-2):53-9. PubMed ID: 11404002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.